UroMetrics Eros-CTD For Female Sexual Dysfunction To List For $359
This article was originally published in The Gray Sheet
Executive SummaryUroMetrics' Eros-CTD vacuum-based clitoral therapy device for treating female sexual dysfunction (FSD) will list for $359. Launched May 3 at the American Urological Association annual meeting in Atlanta, the device gained FDA 510(k) clearance April 28 to improve "sensation, lubrication, orgasm and overall satisfaction," UroMetrics says.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.